跳至主要内容
临床试验/NL-OMON48574
NL-OMON48574招募中不适用

Cardiopulmonary toxicity of thoracic radiotherapy. - CLARIFY

niversitair Medisch Centrum Groningen0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with oesophageal cancer in the mid or distal oesophagus and patients
  • with NSCLC stage IIA-III or NSCLC stage IV with limited brain metastases
  • (treatable with surgery or stereotactic radiosurgery) or SCLC limited disease
  • (stage I-IIIB)
  • Scheduled for external-beam radiotherapy with curative intention.
  • WHO 0-2.
  • Age >= 18 years
  • Written informed consent.

排除标准

  • Heart failure in the last 2 months
  • Pulmonary embolism in the last 2 months
  • COPD gold IV
  • History of thoracic radiotherapy
  • Noncompliance with any of the inclusion criteria
  • - For MRI part: Contra indications for MRIFor MRI part:
  • contra-indications for MRI

研究者

相似试验